BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 4671892)

  • 1. Degeneration of central noradrenaline neurons after 6-hydroxydopamine in newborn animals.
    Sachs C; Jonsson G
    Res Commun Chem Pathol Pharmacol; 1972 Jul; 4(1):203-20. PubMed ID: 4671892
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of tyrosine hydroxylase inhibition on the action of 6-hydroxydopamine.
    Jonsson G; Sachs C
    Res Commun Chem Pathol Pharmacol; 1973 Mar; 5(2):287-96. PubMed ID: 4144667
    [No Abstract]   [Full Text] [Related]  

  • 3. Actions of 6-hydroxydopamine quinones on catecholamine neurons.
    Jonsson G; Sachs C
    J Neurochem; 1975 Oct; 25(4):509-16. PubMed ID: 1173817
    [No Abstract]   [Full Text] [Related]  

  • 4. Changes in central noradrenaline neurons after systemic 6-hydroxydopamine administration.
    Sachs C; Jonsson G
    J Neurochem; 1973 Dec; 21(6):1517-24. PubMed ID: 4771442
    [No Abstract]   [Full Text] [Related]  

  • 5. 6-Hydroxydopamine induced degeneration of noradrenaline neurons in the scorbutic guinea-pig.
    Jonsson G; Lohmander S; Sachs C
    Biochem Pharmacol; 1974 Sep; 23(18):2585-93. PubMed ID: 4153539
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacological modifications of the 6-hydroxy-dopa induced degeneration of central noradrenaline neurons.
    Jonsson G; Sachs C
    Biochem Pharmacol; 1973 Jul; 22(14):1709-16. PubMed ID: 4715992
    [No Abstract]   [Full Text] [Related]  

  • 7. Biochemical and functional evaluation of the sympathectomy produced by the administration of guanethidine to newborn rats.
    Johnson EM; Cantor E; Douglas JR
    J Pharmacol Exp Ther; 1975 May; 193(2):503-12. PubMed ID: 238023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-lasting peripheral and central effects of 6-hydroxydopamine in rats.
    Clark DW; Laverty R; Phelan EL
    Br J Pharmacol; 1972 Feb; 44(2):233-43. PubMed ID: 4677508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of the blood-brain barrier for 6-hydroxydopamine.
    Sachs C
    J Neurochem; 1973 Jun; 20(6):1753-60. PubMed ID: 4719317
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects of the intraventricular injection of 6-hydroxydopamine. I. On the cerebral monoamines of the cat].
    Petitjean F; Laguzzi R; Sordet F; Jouvet M; Pujol JF
    Brain Res; 1972 Dec; 48():281-93. PubMed ID: 4645209
    [No Abstract]   [Full Text] [Related]  

  • 11. 6-Aminodopamine-induced degeneration of catecholamine neurons.
    Jonsson G; Sachs C
    J Neurochem; 1973 Jul; 21(1):117-24. PubMed ID: 4720890
    [No Abstract]   [Full Text] [Related]  

  • 12. Resistance of central phenylethanolamine-n-methyl transferase containing neurons to 6-hydroxydopamine.
    Jonsson G; Fuxe K; Hökfelt T; Goldstein M
    Med Biol; 1976 Dec; 54(6):421-6. PubMed ID: 1004027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proceedings: Impaired response control in the rat after 6-hydroxydopamine lesions to the dorsal noradrenaline bundles.
    Iversen SD; Mason ST
    Br J Pharmacol; 1975 Oct; 55(2):293P. PubMed ID: 1201421
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of nerve degeneration by 6-hydroxydopamine on catecholamine-stimulated adenosine 3',5'-monophosphate formation in rat cerebral cortex.
    Kalisker A; Rutledge CO; Perkins JP
    Mol Pharmacol; 1973 Sep; 9(5):619-29. PubMed ID: 4363016
    [No Abstract]   [Full Text] [Related]  

  • 15. Noradrenaline and dopamine interaction in rat brain during development.
    Ponzio F; Hallman H; Jonsson G
    Med Biol; 1981 Jun; 59(3):161-9. PubMed ID: 6796787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transmitter-dependent changes of equilibrium characteristics of catecholamine synaptosomes in sucrose density gradients.
    Pycock C; Jonsson G
    Med Biol; 1974 Aug; 52(4):260-8. PubMed ID: 4371596
    [No Abstract]   [Full Text] [Related]  

  • 17. 6-hydroxydopamine, 6-hydroxydopa and degeneration of adrenergic nerves.
    de Champlain J; Nadeau R
    Fed Proc; 1971; 30(3):877-85. PubMed ID: 4324975
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of drugs on the 6-hydroxydopamine induced degeneration of adrenergic nerves.
    Jonsson G; Malmfors T; Sachs C
    Res Commun Chem Pathol Pharmacol; 1972 May; 3(3):543-56. PubMed ID: 5034513
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of 6-hydroxydopamine on cardiovascular responses in adrenal denervated dogs.
    Trippodo NC; Traber DL
    J Pharmacol Exp Ther; 1974 Jun; 189(3):633-7. PubMed ID: 4843164
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanisms of selective depletion of brain regional noradrenaline by systemic 6-hydroxydopamine in newborn rats.
    Liew MC; Laverty R
    Eur J Pharmacol; 1975 Aug; 33(1):165-72. PubMed ID: 1175683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.